
Smart Biosensing Technologies for Early Detection of Metabolic Disorders
Academic Press
Will be published approx. on 30. September 2026
Book
Paperback/Softback
400 pages
978-0-443-45911-5 (ISBN)
Description
Smart Biosensing Technologies for Early Detection of Metabolic Disorders gives a clear overview of the latest biosensor tools that help detect and monitor metabolic diseases like diabetes, obesity, and insulin resistance early. It explains how these sensors work using basic science and shows new wearable, non-invasive, and easy-to-use devices. This book is useful for researchers, doctors, and professionals working in healthcare technology. This book connects research from different fields to help solve real problems in making and using biosensors. It includes examples of how these sensors are used, new markers for disease detection, and how AI and digital health can improve care. Readers will learn how to develop better diagnostic tools and improve treatment for metabolic diseases.
More details
Language
English
Place of publication
San Diego
United States
Publishing group
Elsevier Science Publishing Co Inc
Target group
Professional and scholarly
Product notice
Paperback (trade)
Unsewn / adhesive bound
Dimensions
Height: 235 mm
Width: 191 mm
ISBN-13
978-0-443-45911-5 (9780443459115)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Persons
Dr. Kanwal Rehman is working as an Associate Professor at the Department of Pharmacy in The Women University, Multan, Pakistan. Dr. Rehman received her PhD in Pharmacology from Zhejiang University, China. She nurtures
a keen interest in the pathogenesis of metabolic disorders and new therapeutic modalities for its treatment. Currently, she
is focusing on the investigation of the role of pharmacogenomics based upon gene polymorphism on various molecular and
metabolic pathways that are involved in mitogenic disorders and treatment strategies, like natural biogenic compounds against different risk factors of metabolic disorders, including pancreatitis, cardiometabolic disorders, and hormonal imbalance. Dr. Rehman has also been awarded the Research Productivity Award by the Pakistan Council for Science and Technology, Pakistan; the PAS Gold Medal from the Pakistan Academy of Sciences; and the A.R. Shakoori Gold Medal from the Zoological Society of Pakistan. Dr. Akash is currently working as an Associate Professor at the Department of Pharmaceutical Chemistry, Government College University Faisalabad, Pakistan. He got his PhD degree in Pharmaceutical Analysis from Zhejiang University, China. Currently, he is focusing on investigating the effect of endocrine disrupting
chemicals on various molecular and metabolic pathways that are involved in metabolic disorders and their treatment strategies. His research work is cutting-edge and worthy of extension in developing countries, like Pakistan, where it can be most beneficial and cost-effective, especially for diabetic patients. Based on his significant scientific contributions in
the field of Pharmaceutical Sciences, he has been awarded "Research Productivity Awards? from the Pakistan Council for Science and Technology, the PAS Gold Medal from the Pakistan Academy of Sciences, and the A.R. Shakoori Gold Medal from the Zoological Society of Pakistan.
a keen interest in the pathogenesis of metabolic disorders and new therapeutic modalities for its treatment. Currently, she
is focusing on the investigation of the role of pharmacogenomics based upon gene polymorphism on various molecular and
metabolic pathways that are involved in mitogenic disorders and treatment strategies, like natural biogenic compounds against different risk factors of metabolic disorders, including pancreatitis, cardiometabolic disorders, and hormonal imbalance. Dr. Rehman has also been awarded the Research Productivity Award by the Pakistan Council for Science and Technology, Pakistan; the PAS Gold Medal from the Pakistan Academy of Sciences; and the A.R. Shakoori Gold Medal from the Zoological Society of Pakistan. Dr. Akash is currently working as an Associate Professor at the Department of Pharmaceutical Chemistry, Government College University Faisalabad, Pakistan. He got his PhD degree in Pharmaceutical Analysis from Zhejiang University, China. Currently, he is focusing on investigating the effect of endocrine disrupting
chemicals on various molecular and metabolic pathways that are involved in metabolic disorders and their treatment strategies. His research work is cutting-edge and worthy of extension in developing countries, like Pakistan, where it can be most beneficial and cost-effective, especially for diabetic patients. Based on his significant scientific contributions in
the field of Pharmaceutical Sciences, he has been awarded "Research Productivity Awards? from the Pakistan Council for Science and Technology, the PAS Gold Medal from the Pakistan Academy of Sciences, and the A.R. Shakoori Gold Medal from the Zoological Society of Pakistan.
Author
Associate Professor, Department of Pharmacy in The Women University, Multan, Pakistan
Associate Professor and Chairman at Department of Pharmaceutical Chemistry, Government College University Faisalabad (GCUF), Pakistan
Content
Section I: Foundations of Biosensing and Metabolic Disorders
1. Introduction to Metabolic Disorders and Diagnostic Needs
2. Biomarkers of Metabolic Disorders: Molecular, Genetic, Proteomic, and Biophysical Insights
3. Principles and Platforms of Biosensing Technologies: Physical, Molecular and Biophysical Detection Mechanisms
Section II: Emerging Biosensing Platforms for Biomarker Detection
4. Nanomaterial-Based Biosensors: Sensitivity, Selectivity, and Nano-Biophysical Interactions
5. Microfluidic, Lab-on-a-Chip, and Paper-Based Devices for Point-of-Care Diagnostics
6. Optical, Electrochemical, and Wearable Biosensors for Metabolic Health Monitoring
Section III: Smart and Intelligent Biosensing Approaches
7. Artificial Intelligence and Machine Learning in Biosensing Data Analytics
8. Internet of Medical Things (IoMT) and Cloud-Connected Biosensors
9. Smart Wearables and Implantable Biosensors for Continuous Monitoring
Section IV: Applications in Early Detection of Specific Metabolic Disorders
10. Biosensing Approaches for Diabetes and Its Complications
11. Smart Biosensors for Obesity and Metabolic Syndrome Detection
12. Biosensing Strategies for Cardiometabolic Biomarkers
13. Biomarker Detection for Rare and Inherited Metabolic Disorders
14. Monitoring Oxidative Stress and Inflammation in Metabolic Disorders: Biosensing and Biophysical Methods
Section V: Translational Perspectives and Future Directions
15. Regulatory, Ethical, and Commercialization Challenges in Smart Biosensing
1. Introduction to Metabolic Disorders and Diagnostic Needs
2. Biomarkers of Metabolic Disorders: Molecular, Genetic, Proteomic, and Biophysical Insights
3. Principles and Platforms of Biosensing Technologies: Physical, Molecular and Biophysical Detection Mechanisms
Section II: Emerging Biosensing Platforms for Biomarker Detection
4. Nanomaterial-Based Biosensors: Sensitivity, Selectivity, and Nano-Biophysical Interactions
5. Microfluidic, Lab-on-a-Chip, and Paper-Based Devices for Point-of-Care Diagnostics
6. Optical, Electrochemical, and Wearable Biosensors for Metabolic Health Monitoring
Section III: Smart and Intelligent Biosensing Approaches
7. Artificial Intelligence and Machine Learning in Biosensing Data Analytics
8. Internet of Medical Things (IoMT) and Cloud-Connected Biosensors
9. Smart Wearables and Implantable Biosensors for Continuous Monitoring
Section IV: Applications in Early Detection of Specific Metabolic Disorders
10. Biosensing Approaches for Diabetes and Its Complications
11. Smart Biosensors for Obesity and Metabolic Syndrome Detection
12. Biosensing Strategies for Cardiometabolic Biomarkers
13. Biomarker Detection for Rare and Inherited Metabolic Disorders
14. Monitoring Oxidative Stress and Inflammation in Metabolic Disorders: Biosensing and Biophysical Methods
Section V: Translational Perspectives and Future Directions
15. Regulatory, Ethical, and Commercialization Challenges in Smart Biosensing